Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary bilateral adrenal lymphoma

F Z Al-Fiar1, D Pantalony, F Shepherd

  • 1Department of Medicine, The Toronto Hospital and the University of Toronto, Ontario, Canada.

Leukemia & Lymphoma
|February 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The feeding of heather (Calluna vulgaris) to Teladorsagia circumcincta infected lambs reduces parasitism but can detrimentally impact performance.

Veterinary journal (London, England : 1997)·2024
Same author

Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2003
Same author

The PIVKA II test: the first reliable coagulation test for autopsy investigations.

International journal of legal medicine·2003
Same author

Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization.

Cancer genetics and cytogenetics·2001
Same author

Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160).

The Journal of thoracic and cardiovascular surgery·2001
Same author

No association between hepatitis C and B-cell lymphoma.

Hepatology (Baltimore, Md.)·1999
Same journal

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Leukemia & lymphoma·2026
Same journal

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

Leukemia & lymphoma·2026
Same journal

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

Leukemia & lymphoma·2026
Same journal

T-box factor EOMES is part of an aberrant network in Hodgkin lymphoma.

Leukemia & lymphoma·2026
Same journal

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.

Leukemia & lymphoma·2026
Same journal

Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naïve CLL/SLL.

Leukemia & lymphoma·2026
See all related articles

Primary bilateral adrenal non-Hodgkins lymphoma (NHL) is rare and presents distinct features. This condition often leads to delayed diagnosis and poor outcomes, highlighting a critical clinical challenge.

Area of Science:

  • Oncology
  • Endocrinology
  • Pathology

Background:

  • Non-Hodgkins lymphoma (NHL) rarely involves the adrenal glands primarily.
  • Primary bilateral adrenal NHL presents a unique clinical and pathological entity.

Observation:

  • The case involved primary bilateral adrenal non-Hodgkins lymphoma with hypercalcemia.
  • Literature review confirmed the rarity of this specific lymphoma site.

Findings:

  • This rare lymphoma subtype exhibits distinct features compared to general NHL or extranodal NHL.
  • Diagnosis is often missed antemortem, with significant delays from symptom onset.
  • Adrenal insufficiency is a frequent and potentially lethal complication.

Implications:

Related Experiment Videos

  • Early recognition and diagnosis are crucial for managing this rare condition.
  • Adrenal insufficiency poses a significant threat, requiring vigilant monitoring.
  • Therapeutic response and patient survival rates are notably poor for primary adrenal NHL.